Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome
- DOI
- 10.1111/exd.70113
- Published
- 2025-05
- Container
- Experimental Dermatology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/exd.70113,
title = {Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome},
author = {Stefan Blunder and Natascha Hermann‐Kleiter and Rita Mahmuti and Martin Hermann and Daniela Ortner and Daniela Reider and Verena Moosbrugger‐Martinz and Barbara Del Frari and Patrizia Stoitzner and Sandrine Dubrac and Matthias Schmuth and Robert Gruber},
year = {2025},
journal = {Experimental Dermatology},
doi = {10.1111/exd.70113},
url = {https://doi.org/10.1111/exd.70113}
}RIS
TY - JOUR TI - Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome AU - Stefan Blunder AU - Natascha Hermann‐Kleiter AU - Rita Mahmuti AU - Martin Hermann AU - Daniela Ortner AU - Daniela Reider AU - Verena Moosbrugger‐Martinz AU - Barbara Del Frari AU - Patrizia Stoitzner AU - Sandrine Dubrac AU - Matthias Schmuth AU - Robert Gruber PY - 2025 JO - Experimental Dermatology DO - 10.1111/exd.70113 UR - https://doi.org/10.1111/exd.70113 ER -
APA
Blunder, S., Hermann‐Kleiter, N., Mahmuti, R., Hermann, M., Ortner, D., Reider, D., Moosbrugger‐Martinz, V., Frari, B. D., Stoitzner, P., Dubrac, S., Schmuth, M., & Gruber, R. (2025). Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome. Experimental Dermatology. https://doi.org/10.1111/exd.70113
Source records
- crossref · retrieved 2026-09-27T05:26:01.334Z